161 related articles for article (PubMed ID: 25448485)
1. Human placental growth hormone: a potential new biomarker in gestational trophoblastic disease.
Hübener C; Bidlingmaier M; Wu Z; Diebold J; Delius M; Friese K; Strasburger CJ; Hasbargen U
Gynecol Oncol; 2015 Feb; 136(2):264-8. PubMed ID: 25448485
[TBL] [Abstract][Full Text] [Related]
2. Human placental growth hormone in ectopic pregnancy: Detection in maternal blood, immunohistochemistry and potential clinical implication.
Hübener C; Bidlingmaier M; Wu Z; Diebold J; Strasburger CJ; Mahner S; Hasbargen U; Delius M
Growth Horm IGF Res; 2017 Dec; 37():13-18. PubMed ID: 29073481
[TBL] [Abstract][Full Text] [Related]
3. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
4. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
5. p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases.
Shoni M; Nagymanyoki Z; Vitonis AF; Jimenez C; Ng SW; Quade BJ; Berkowitz RS
Gynecol Oncol; 2013 Dec; 131(3):759-63. PubMed ID: 24051221
[TBL] [Abstract][Full Text] [Related]
6. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
7. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases.
Buza N; Hui P
Semin Diagn Pathol; 2014 May; 31(3):223-32. PubMed ID: 24907943
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of cyclin E, p63, and Ki-67 in gestational trophoblastic disease and its role in diagnosis and management: A prospective case-control study.
Kar A; Mishra C; Biswal P; Kar T; Panda S; Naik S
Indian J Pathol Microbiol; 2019; 62(1):54-60. PubMed ID: 30706860
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic disease: an overview.
Monchek R; Wiedaseck S
J Midwifery Womens Health; 2012; 57(3):255-9. PubMed ID: 22587615
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1.
Briese J; Oberndörfer M; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):271-6. PubMed ID: 15968204
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 20 as a biomarker of gestational trophoblastic disease: diagnostic and prognostic significance.
Stackievicz R; Drucker L; Zemer R; Klein A; Markovitch O; Yarkoni S
Gynecol Oncol; 2002 Oct; 87(1):34-8. PubMed ID: 12468339
[TBL] [Abstract][Full Text] [Related]
14. Histologic classification and staging of gestational trophoblastic disease.
Horn LC; Bilek K
Gen Diagn Pathol; 1997 Nov; 143(2-3):87-101. PubMed ID: 9443566
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions.
Briese J; Sudahl S; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):265-70. PubMed ID: 15968203
[TBL] [Abstract][Full Text] [Related]
16. Versican silencing in BeWo cells and its implication in gestational trophoblastic diseases.
Pires KSN; Sun SY; Gonçalves CM; Santos JC; Tenorio LPG; Botelho RM; Silva ALM; Oliveira HGS; Pendeloski KPT; Daher S; Borbely KSC; Borbely AU
Histochem Cell Biol; 2019 Apr; 151(4):305-313. PubMed ID: 30298299
[TBL] [Abstract][Full Text] [Related]
17. Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases.
Bolze PA; Attia J; Massardier J; Seckl MJ; Massuger L; van Trommel N; Niemann I; Hajri T; Schott AM; Golfier F;
Eur J Cancer; 2015 Sep; 51(13):1725-31. PubMed ID: 26092638
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression.
Wu W; Wang Y; Xu Y; Liu Y; Wang Y; Zhang H
Placenta; 2014 Oct; 35(10):824-30. PubMed ID: 25108485
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and aetiology of gestational trophoblastic diseases.
Altieri A; Franceschi S; Ferlay J; Smith J; La Vecchia C
Lancet Oncol; 2003 Nov; 4(11):670-8. PubMed ID: 14602247
[TBL] [Abstract][Full Text] [Related]
20. Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.
Rumer KK; Post MD; Larivee RS; Zink M; Uyenishi J; Kramer A; Teoh D; Bogart K; Winn VD
Endocr Relat Cancer; 2012 Dec; 19(6):827-40. PubMed ID: 23089140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
